IRIDEX CORP — Director's Dealing 2014

Sep 5, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IRIDEX CORP (IRIX)
CIK: 0001006045
Period of Report: 2014-09-05

Reporting Person: BlueLine Catalyst Fund IX, L.P. (Director, 10% Owner)
Reporting Person: BlueLine Capital Partners, L.P. (Director, 10% Owner)
Reporting Person: BlueLine Capital Partners II, L.P. (Director, 10% Owner)
Reporting Person: BlueLine Capital Partners III, LP (Director, 10% Owner)
Reporting Person: BlueLine Partners, L.L.C. (Director, 10% Owner)
Reporting Person: BlueLine Partners II, LLC (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-09-03	Common Stock	P	300	$7.98	Disposed	2522105	Direct
2014-09-04	Common Stock	P	200	$7.99	Disposed	2522305	Direct
2014-09-05	Common Stock	P	7932	$7.99	Disposed	2530237	Direct

Footnotes

F1: These securities were acquired by BlueLine Catalyst Fund IX, L.P. As described in Amendment No. 4 to Schedule 13D ("Amendment No. 4") filed on October 25, 2007 with respect to the securities owned by BlueLine Capital Partners, L.P., BlueLine Capital Partners II, L.P., BlueLine Capital Partners III, L.P., BlueLine Catalyst Fund VIII, L.P., BlueLine Catalyst Fund IX, L.P., BlueLine Partners, L.L.C., and BlueLine Partners II, L.L.C., as of the date of Amendment No. 4, the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Entity may have been deemed to have beneficial ownership of 10% or more of the securities.